5Love PE,Santoro SA.Antiphospholipid antibodies:anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus(SLE) and in non-SLE disorders[J].Ann Intern Med,1990,112(9):682-698.
8Briley DP,Coull BM,Goodnight SH.Neurological disease associated with anticardiolipid antibodies[J].Ann Neurol,1989,25:221.
二级参考文献8
1邹万忠，肾脏病理与临床，1993年，4页
2Asherson RA,Cervera R.Primary,"Secondary" and other variants of the antiphospholipid syndrome.Lupus,1994,3(5):293.
3John GF,Susan FC,John L,et al.Anticardiolipin antibodies in patients with rheumatic diseases.Arth Rheumat,1987,30(7):752-760.
4Aguirre V,Cuchacovich R,Barria L,et al.Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE).Lupus,2001,10(2):75-80.
5Pope JE,Thompson A.The frequency and significance of anticardiolipin antibodies in scleroderma.J Rheumatol,2000,27(6):1450-1452.
6Roussel V.Prevalence and clinical significance of antiphospholipid antibodies in multiple sclerosis:a study of 89 patients.J Autoimmun,2000,14(3):259-265.
7Ordi-Ros J,Villarreal J,Monegal F,et al.Anticardiolipin antibodies in patients with chronic hepatitis C virus infection characterization in relation to antiphospholipid syndrome.Clin Diagn Lab Immunol,2000,7(2):241-244.
8Lossos IS,Bogomolski-Yahalom V,Matzner Y.Anticardiolipin antibodies in acute myeloid leukemia:prevalence and clinical significance.Am J Hematol,1998,57(2):139-143.
